Prelude Therapeutics
PRLD
PRLD
47 hedge funds and large institutions have $82.5M invested in Prelude Therapeutics in 2025 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
80% less call options, than puts
Call options by funds: $19K | Put options by funds: $97K
Holders
47
Holding in Top 10
–
Calls
$19K
Puts
$97K
Top Buyers
| 1 | +$1.33M | |
| 2 | +$1.07M | |
| 3 | +$711K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$462K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$229K |
Top Sellers
| 1 | -$1.68M | |
| 2 | -$460K | |
| 3 | -$203K | |
| 4 |
SC
Shay Capital
New York
|
-$144K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$108K |
